Table 1.

Association between MIC1 SNPs and prostate cancer risk (N = 1,012)

Controls, n (%)Case, n (%)OR (95% CI)*P
H6D (rs1058587)
    CC273 (54.1)292 (58.1)1
    CG205 (40.6)180 (35.8)0.82 (0.63-1.07)0.14
    GG27 (5.4)31 (6.2)1.07 (0.62-1.85)0.81
    CG/GG232 (45.9)211 (42.0)0.85 (0.66-1.09)0.20
rs1059519
    CC245 (48.4)224 (44.3)1.00
    CG206 (40.7)225 (44.5)1.05 (0.69-1.60)0.81
    GG55 (10.9)57 (11.3)0.88 (0.58-1.33)0.54
rs1059369
    TT317 (62.8)314 (62.2)1.00
    AT161 (31.9)156 (30.9)0.98 (0.75-1.28)0.88
    AA27 (5.4)35 (6.9)1.31 (0.77-2.22)0.32
rs1227731
    GG382 (75.5)388 (76.7)1.00
    AG118 (23.3)114 (22.5)0.95 (0.71-1.28)0.73
    AA6 (1.2)4 (0.8)0.65 (0.18-2.34)0.51
rs16982345
    GG277 (54.7)293 (58.0)1.00
    AG204 (40.3)178 (35.3)0.82 (0.63-1.07)0.14
    AA25 (4.9)34 (6.7)1.29 (0.75-2.22)0.37
rs8101249
    AA309 (61.2)318 (63.0)1.00
    AC160 (31.7)160 (31.7)0.95 (0.72-1.26)0.74
    CC36 (7.1)27 (5.4)0.69 (0.39-1.21)0.19
  • * Adjusted for age, racial/ethnic group, and institution.

  • CG is the reverse strand.